Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Meclofenamate in Progressive MGMT-methylated Glioblastoma Under Temozolomide Second-line Therapy
DRKS00025207Phase 2Recruiting
- Sponsor
- University of Bonn
- Start
- Jul 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of Meclofenamic acid in glioblastoma (GBM), sponsored by University of Bonn. Started Jul 2021; status: recruiting.
02
Drugs
Meclofenamic acid
03
Conditions
glioblastoma (GBM)
Beyond the preview
Go deeper on DRKS00025207.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on DRKS00025207.